Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127140701 | 12714070 | 1 | I | 20160824 | 20160905 | 20160905 | EXP | DE-BAUSCH-BL-2016-021259 | BAUSCH AND LOMB | EFFERTH T, SCHOTTLER U, KRISHNA S, SCHMIEDEK P, WENZ F, GIORDANO F. HEPATOTOXICITY BY COMBINATION TREATMENT OF TEMOZOLOMIDE, ARTESUNATE AND CHINESE HERBS IN A GLIOBLASTOMA MULTIFORME PATIENT: CASE REPORT REVIEW OF THE LITERATURE.. ARCHIVES OF TOXICOLOGY. 2016;1-14. | 65.00 | YR | Y | 0.00000 | 20160905 | MD | DE | DE |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127140701 | 12714070 | 1 | PS | LORAZEPAM. | LORAZEPAM | 1 | Unknown | U | 17794 | ||||||||||
| 127140701 | 12714070 | 2 | SS | CLOBAZAM | CLOBAZAM | 1 | Unknown | U | 0 | ||||||||||
| 127140701 | 12714070 | 3 | SS | TEMOZOLOMIDE. | TEMOZOLOMIDE | 1 | Unknown | U | 0 | ||||||||||
| 127140701 | 12714070 | 4 | SS | VALPROIC ACID. | VALPROIC ACID | 1 | Unknown | U | 0 | ||||||||||
| 127140701 | 12714070 | 5 | SS | ARTESUNATE | ARTESUNATE | 1 | Unknown | Y | 0 | ||||||||||
| 127140701 | 12714070 | 6 | SS | ONDANSETRON | ONDANSETRON | 1 | Unknown | U | 0 | ||||||||||
| 127140701 | 12714070 | 7 | SS | LEVETIRACETAM. | LEVETIRACETAM | 1 | Unknown | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127140701 | 12714070 | 1 | Product used for unknown indication |
| 127140701 | 12714070 | 2 | Product used for unknown indication |
| 127140701 | 12714070 | 3 | Glioblastoma multiforme |
| 127140701 | 12714070 | 4 | Product used for unknown indication |
| 127140701 | 12714070 | 5 | Product used for unknown indication |
| 127140701 | 12714070 | 6 | Product used for unknown indication |
| 127140701 | 12714070 | 7 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127140701 | 12714070 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127140701 | 12714070 | Condition aggravated | |
| 127140701 | 12714070 | Hepatotoxicity | |
| 127140701 | 12714070 | Product use issue |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |